Managing external dependence: a study on the effects of external factors on firm behaviour and performance

Paper 1. Enjoy today because nothing is sure about tomorrow: unintended consequences of eligibility for debt suspension. Paper 2. What determines firm investments? An empirical investigation on the role of local institutional quality, industry regulation and state ownership. Paper 3. Working more or working less? The impact of shop opening hours deregulation on firm performance

The CSR committee as moderator for the ESG score and market value

This paper investigates the relationship between the ESG score and market values. Specifically, we test the moderating role of CSR committee defined as organizational subcommittees of boards of directors that make social and environmental recommendationsto the boards of directors and support members in their CSR-related tasks. We built a panel data set with all the listed companies in STOXX Europe 600, covering the period 2014–2020. Firms' data come from Refinitiv Eikon database which contains financial and ESG scores data of all EU listed companies. Our sample of firm-level data contains a dataset of 600 European listed companies which are part of the STOXX Europe 600 Index. We included ESG data of STOXX Europe 600 Index components in the period 2014–2020. Our dataset contains a total of 4800 firm-year observations. We found a negative relationship between ESG score and stock prices while the presence of CSR committee as moderating variable generates no significant evidence of ESG score. The presence of CSR committee is not considerably supporting ESG in achieving higher market performance. The CSR committee plays an essential role in monitoring management activities. This may support management practitioners in better understanding and reacting to stakeholder expectations

Sustainability disclosure and IPO performance: exploring the impact of ESG reporting

Investors are increasingly concerned with the sustainability of firms and their impact on global development, resulting in a rise in Socially Responsible Investing (SRI) that considers environmental, social, and governance (ESG) factors. Integrating sustainability into company strategies can affect various aspects of an organization, including IPOs (initial public offerings). Given the growing importance of ESG information disclosure, this study wants to examine the potential effect of an ESG report disclosure on IPO performance, since there are not studies focused on analyzing how ESG factors and IPO performance are correlated. The purpose of this study is to examine how ESG disclosure affects IPO underpricing and increases transparency for stakeholders to reduce information asymmetry. This study explores the impact of disclosing ESG information on IPO underpricing using a sample of 100 European IPOs from 2017 to 2021, with 50 firms disclosing an ESG report prior to the IPO and 50 that did not. The results showed that the publication of a sustainable report before an IPO has a positive effect on underpricing by reducing it. This finding suggests that companies that publish sustainability reports are perceived to be less risky, and investors value ESG disclosure as a tool to reduce the risks associated with ESG issues. The work contributes to the research on firms’ incentives to disclose ESG information. Our study is limited by the size of the sample, which is limited and only focused on European companies; therefore, future studies should consider companies from other parts of the world, and with more data related to IPO performance

INFLUENCE OF AVERAGE POWER FACTOR MANAGEMENT ON ACTIVE DISTRIBUTION NETWORKS

ABSTRAC

A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis

Background To date, measurement of intracellular cystine is used for the therapeutic monitoring of patients affected by cystinosis in treatment with cysteamine. Since this method is time and sample consuming, development of a faster method to quantify cysteamine would be extremely useful in order to help clinicians to adjust dosages of cysteamine and to define better the pharmacokinetic profile of this drug. The aim of the study was to develop a liquid chromatography tandem mass spectrometry method for the quantification of cysteamine in plasma samples and to test its applicability on plasma samples derived from patients with nephropathic infantile cystinosis in treatment with cysteamine. Results The percentage of accuracy of the developed method varied between 97.80 and 106.00% and CV% between 0.90 and 6.93%. There was no carry over. The calibration curves were built from 2.5 to 50 mu M. The limit of detection and the lower limit of quantification occurred at 0.25 and 1.25 mu M respectively. Cysteamine was stable up to 2 months at -20 degrees C. Concentrations of cysteamine and intracellular cystine of 4 patients were in line with data previously reported. Conclusion The proposed method showed an appropriate selectivity, specificity, linearity, sensibility, accuracy, precision and good applicability to samples

Analysis of urban greening scenarios for improving outdoor thermal comfort in neighbourhoods of Lecce (Southern Italy)

This study analyses the interactions and impacts between multiple factors i.e., urban greening, building layout, and meteorological conditions that characterise the urban microclimate and thermal comfort in the urban environment. The focus was on two neighbourhoods of Lecce city (southern Italy) characterised through field campaigns and modelling simulations on a typical hot summer day. Field campaigns were performed to collect greening, building geometry, and microclimate data, which were employed in numerical simulations of several greening scenarios using the Computational Fluid Dynamics-based and microclimate model ENVI-met. Results show that, on a typical summer day, trees may lead to an average daily decrease of air temperature by up to 1.00 °C and an improvement of thermal comfort in terms of Mean Radiant Temperature (MRT) by up to 5.53 °C and Predicted Mean Vote (PMV) by up to 0.53. This decrease is more evident when the urban greening (in terms of green surfaces and trees) is increased by 1266 m2 in the first neighbourhood and 1988 m2 in the second one, with respect to the current scenario, proving that shading effect mainly contributes to improving the urban microclimate during daytime. On the contrary, the trapping effect of heat, stored by the surfaces during the day and released during the evening, induces an increase of the spatially averaged MRT by up to 2 °C during the evenings and a slight deterioration of thermal comfort, but only locally where the concentration of high LAD trees is higher. This study contributes to a better understanding of the ecosystem services provided by greening with regard to microclimate and thermal comfort within an urban environment for several hours of the day. It adds knowledge about the role of green areas in a Mediterranean city, an important hot spot of climate change, and thus it can be a guide for important urban regeneration plans

Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice

Unlabelled: Urachal carcinoma is a rare urological disease. The shortage of data about diagnosis and surgical treatment in literature makes it hard for clinicians to make a decision. Indeed, urachal carcinoma is an aggressive disease that requires prompt staging and treatment to ensure the best outcome for patients. We reviewed the last evidence about the management of urachal carcinoma to provide an easy-to-use guide for clinical practice. Patient summary: Urachal carcinoma is a rare malignancy. The literature on this challenging disease remains limited. Herein, we provide a practical guide for its management from diagnosis to treatment, which in most cases requires surgical intervention or chemotherapy

Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer

Metabolomic analysis has proven to be a useful tool in biomarker discovery and the molecular classification of cancers. In order to find new biomarkers, and to better understand its pathological behavior, bladder cancer also has been studied using a metabolomics approach. In this article, we review the literature on metabolomic studies of bladder cancer, focusing on the different available samples (urine, blood, tissue samples) used to perform the studies and their relative findings. Moreover, the multi-omic approach in bladder cancer research has found novel insights into its metabolic behavior, providing excellent start-points for new diagnostic and therapeutic strategies. Metabolomics data analysis can lead to the discovery of a “signature pathway” associated with the progression of bladder cancer; this aspect could be potentially valuable in predictions of clinical outcomes and the introduction of new treatments. However, further studies are needed to give stronger evidence and to make these tools feasible for use in clinical practice

Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets

: Clear cell renal cell carcinoma (ccRCC) is the most frequent histological kidney cancer subtype. Over the last decade, significant progress has been made in identifying the genetic and metabolic alterations driving ccRCC development. In particular, an integrated approach using transcriptomics, metabolomics, and lipidomics has led to a better understanding of ccRCC as a metabolic disease. The metabolic profiling of this cancer could help define and predict its behavior in terms of aggressiveness, prognosis, and therapeutic responsiveness, and would be an innovative strategy for choosing the optimal therapy for a specific patient. This review article describes the current state-of-the-art in research on ccRCC metabolic pathways and potential therapeutic applications. In addition, the clinical implication of pharmacometabolomic intervention is analyzed, which represents a new field for novel stage-related and patient-tailored strategies according to the specific susceptibility to new classes of drugs